(3.239.33.139) 您好!臺灣時間:2021/03/05 17:16
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果

詳目顯示:::

我願授權國圖
: 
twitterline
研究生:邱雅茗
研究生(外文):Ya-Ming Chiu
論文名稱:人類卵巢濾泡中IGFs,IGFBPs及BMPs於預測卵子預後之角色
論文名稱(外文):The roles of IGFs, IGFBPs and BMPs in predicting the outcome of oocytes
指導教授:王子豪王子豪引用關係
指導教授(外文):Tzu-Hao Wang
學位類別:碩士
校院名稱:長庚大學
系所名稱:基礎醫學研究所
學門:醫藥衛生學門
學類:醫學學類
論文種類:學術論文
論文出版年:2005
畢業學年度:93
語文別:中文
論文頁數:116
中文關鍵詞:人類卵細胞類胰島素生長因子濾泡液類胰島素生長因子結合蛋白類胰島素生長因子結合蛋白分解酶
外文關鍵詞:human oocyteIGFsIGFBPsBMPsPAPP-A
相關次數:
  • 被引用被引用:0
  • 點閱點閱:246
  • 評分評分:系統版面圖檔系統版面圖檔系統版面圖檔系統版面圖檔系統版面圖檔
  • 下載下載:0
  • 收藏至我的研究室書目清單書目收藏:0
本文的目的在探討類卵巢中濾泡液內胰島素生長因子(IGF-II及IGF-II)及其結合蛋白(IGF binding proteins)與IGFBP4之蛋白酶(pregnancy-associated plasma protein-A)、及取卵後卵子之後的發育情況間的關係。
總共有162位不孕婦女進行人工生殖(in vitro fertilization),共收集了241管的濾泡液(FF)檢體且沒有血液污染;此外,這些濾泡液檢體也都有與其相對應之發育成熟的卵細胞,並詳細紀錄卵細胞發育成胚胎的詳細資料。而濾泡液中IGFs、IGFBPs及PAPP-A的濃度則是利用酵素結合免疫吸附法(ELISA)測量而得。
我們發現濾泡液中IGF-II,IGFBP3及IGFBP4的濃度與胚胎發育第三天的分級分數(embryo score)成正相關(其P值依序為:P < 0.02, P < 0.02 and P < 0.005);意即胚胎之第三天的分級分數(embryo score)越高,其濾泡液中IGF-II,IGFBP3及IGFBP4的濃度越高。此外,測量濾泡液中PAPP-A的濃度卻發現與IGFBP4的濃度呈現負相關(P < 0.01)。此外,卵細胞成功受精且發育到第三天的濾泡(Day3 embryo score ³ 5)其濾泡液中IGFBP3及IGFBP4的濃度,比卵細胞沒有受精及胚胎最後沒有成功發育到第三天者(Day3 embryo score = 0)來的高(P< 0.00001及P< 0.00003)。
比較那些沒有成功受精或在受精後72小時後,胚胎停止發育的濾泡(Day3 embryo score =0)其濾泡液中PAPP-A的濃度,與成功受精且胚胎發育至第三天的濾泡(Day3 embryo score ³ 5)之PAPP-A;前者的PAPP-A濃度比後者的高(P< 0.0003)。
以上的實驗結果,可以假設濾泡液中之第二型類胰島素生長因子(insulin-like growth factor II,IGF-II),及其第三、第四結合蛋白(IGFBP3,IGFBP4)的濃度,也許能反應出卵子的成熟度及之後胚胎發育的情況。
The objective of the present study was to investigate the association between levels of insulin-like growth factors (IGF-I and IGTF-II), their binding protein (IGFBP1, IGFBP3 and IGFBP4) and a protease of IGFBP4, pregnancy-associated plasma protein-A (PAPP-A), in follicular fluid (FF) and the quality of subsequent embryo development of the in vitro fertilized oocytes aspirated form the corresponding follicle.
162 infertile women undergoing controlled ovarian hyperstimulation from in vitro fertilization and embryo transfer were recruited. 241 pairs of FF samples and corresponding mature oocytes were studied. Concentration of IGFs, IGFBPs and PAPP-A were determined by enzyme-linked immunosorbent assay (ELISA).
We found that levels of IGF-II, IGFBP3 and IGFBP4 in follicular fluid (FF) were significantly correlated with embryo scores on Day3 (72 hours after oocyte retrieval; embryo score ³ 5) (P < 0.02, P < 0.02 and P < 0.005, respectively). Additionally, concentrations of PAPP-A in FF on the day of oocyte retrieval showed a significantly reverse association with of IGFBP4 (P < 0.01). FF levels of IGFBP3 and IGFBP4 from follicles in which oocytes were fertilized and developed into embryos on Day3 were significantly higher than those follicles both in which oocytes were unfertilized and in which fertilized oocytes fail to develop into Day3 embryos (Day3 embryo score = 0) (P < 0.00001 and P < 0.00003, respectively). Lower levels of PAPP-A in FF were noticed from follicles in which retrieved eggs were fertilized and developed into Day3 embryos as compared to those from follicles in which oocytes were unfertilized and in which fertilized eggs became arrested by 72 hours after oocyte retrieval. Results of this study suggest that insulin-like growth factor-II (IGF-II), IGF-biding protein-3 (IGFBP3) and IGFBP4 in FF at the time of oocyte retrieval may reflect the oocyte maturation and later embryo development.
目錄
指導教授推薦書
口試委員審定書
目錄(Table of content)………………………………………………….I
圖目錄(List of figures)…………………………………………………V
表目錄(List of tables)………………………………………………….VI
附錄(List of appendix)
中文摘要………………………………………………………………VII
英文摘要………………………………………………………………IX
第一章:序論
1.1 濾泡生成過程 (Folliculogenesis)……………………………….1
1.2 累計的胚胎發育分數 (The cumulative embryo score)………. .3
1.3 概觀TGF-b superfamily (Overview of TGF-b superfamily)…....3
1.4 TGF-b superfamily:the bone morphogenetic proteins………….4
1.5 TGF-b superfamily之訊息傳遞路徑……………………………5
1.6 BMP蛋白質在調節濾泡生長及發育所扮演之角色…………..6
1.7 概觀IGFs/IGFBPs系統(Overview of IGF/ IGFBPs systems)…8
1.8 IGFs與IGFBPs所扮演之角色(Role of IGFs/ IGFBPs)……….9

第二章:研究目的與假說……………………………………………..17
2.1 Rationale…………………………………………………………18
2.2 Specific aims……………………………………………………..18
第三章:實驗材料與方法
3.1 誘發排卵的步驟(Protocols of ovulation induction)……………19
3.2 人工生殖與胚胎的評估………………………………………..20
3.3濾泡液的收集(Collection of follicular fluid)…………………...20
3.4 Enzyme-linked immunosorbent assay (ELISA) for IGF-I, IGF-II, IGFBP-1, IGFBP-3, IGFBP-4, PAPP-A………………………………..21
3.5西方墨點分析IGFBP4及Beta-actin之分子量……………….25
3.6收集並培養濾泡顆粒細胞……………………………………...26
3.7 免疫組織化學染色法(Immunohistochemical staining)………..27
3.8 Total RNA的粹取………………………………………………28
3.9 反轉錄聚合鏈反應 (Reverse transcription PCR)……………..29
3.10 Real-time quantitative polymerase chain reaction…………….29
3.11 Primers and Probes………………………………………….…30
3.12 Electroporation…………………………………………………31
3.13 Microinjection of granulosa cells……………………………..32
3.14 轉染 (Transfection)…………………………………………..32
3.15 Reporter vector preparation……………………………………34
3.16 Luciferase assay……………………………………………….36
3.17 cDNA microarray analysis…………………………………….38
3.18 數據分析……………………………………………………...38
3.19 傳統聚合酶鏈反應 (Polymerase Chain Reaction)………….40
3.21 濾泡顆粒細胞之藥物影響…………………………………...41
3.22 Radio immunoassay (RIA) for progesterone………………….42
第四章:實驗結果……………………………………………………44
4.1 收集濾泡中之濾泡液(FF)與該濾泡內卵子並紀錄早期胚胎發育情況…………………………………………………………………44
4.2 濾泡液中各種蛋白質與該濾泡中卵子發育之預後關係……44
4.3 利用免疫組織化學染色法來確認所收集之細胞……………46
4.4 確立real time quantitative PCR的正確性(efficiency)……….47
4.5 顆粒細胞內各種基因表現與該濾泡中卵子發育之預後關係.47
4.6 以微注射或轉染(transfection)將外來基因引導入顆粒細胞…48
4.7 以cDNA microarray來篩選與卵子發育有關之基因………..49
4.8 以傳統聚合鏈反應(PCR)及DNA電泳分析來確認cDNA microarray所篩選出之基因之正確性………………………………..49
4.9 濾泡顆粒細胞的In vitro treatment來看IGF-II、IGFBP3及IGFBP4間對顆粒細胞的影響………………………………………..50
第五章:討論…………………………………………………………52
5.1 由濾泡液著眼IGFs, IGFBPs及PAPP-A於胚胎預後所扮演角色之結果…………………………………………………………………52
5.2 由濾泡顆粒細胞著眼BMPs系統於胚胎預後扮演之角色的結果………………………………………………………………………57
5.3 由DNA微陣列分析篩選出與胚胎預後可能有關之基因…59
5.4 在high embryo score (Day2 embryo score ³ 10)這組,其基因表現被活化之基因……………………………………………………...60
5.5 由In vitro treatment著眼探討IGF-II、IGFBF3及IGFBP4間的交互作用對濾泡顆粒細胞的影響…………………………………..65
第六章:結論………………………………………………………..67
參考文獻…………………………………………………………….68
參考文獻:
Baxter, RC. & Martin, JL. (1986). Radioimmuoassay of growth hormone-dependent insulin like growth factor binding protein in human plasma. J Clin Invest, 78, 1504-12.

Bar, R.S., Booth, B.A., Boes, M. & Dake, B.L. (1989). Insulin-like growth factor-binding proteins from vascular endothelial cells: purification, characterization, and intrinsic biological activities. Endocrinology, 125, 1910-20.

Bayes-Genis, A., Cheryl, AC.& Schwartz, RS. (2000). The Insulin-Like Growth Factor Axis : A Review of Atherosclerosis and Restenosis. Circ Res, 86, 4, 125-30.

Binoux, M., Roghani, M., Hossenlopp, P., Hardouin, S. & Gourmelen, M. (1991). Molecular forms of human IGF binding proteins: physiological implications. Acta Endocrinol (Copenh), 124, 41-7.

Bjersing, L. & Cajander, S. (1975). Ovulation and the role of the ovarian surface epithelium. Experirntia, 31, 605-08.

Brannstrom, M., Norman, RJ., Seamark, RF. & Robertson, SA. (1994). Rat ovary produces cytokines during ovulation. Biol Reprod, 50, 88-94.

Busby, W.H., Jr., Klapper, D.G. & Clemmons, D.R. (1988). Purification of a 31,000-dalton insulin-like growth factor binding protein from human amniotic fluid. Isolation of two forms with different biologic actions. J Biol Chem, 263,14203-10.

Buse, P., Woo, PL., Alexander, DB., Reza, A.& Firestone, GL. (1995). Glucocorticoid-induced functional polarity of growth factor responsiveness regulates tight junction dynamics in transformed mammary epithelial tumor cells. J Biol Chem, 270, 28223-27.

Cataldo, N.A. (1997). Insulin-like growth factor binding proteins: do they play a role in polycystic ovary syndrome? Semin Reprod Endocrinol, 15,123-36.
Chang, S.Y., Hsieh, K.C., Wang, H.S. & Soong, Y.K. (1994). Follicular fluid levels of insulin-like growth factor I, insulin-like growth factor binding protein I, and ovarian steroids collected during ovum pick-up. Fertil Steril, 62,1162-7.

Conover, C.A., Oxvig, C., Overgaard, M.T., Christiansen, M. &Giudice, L.C. (1999). Evidence that the insulin-like growth factor binding protein-4 protease in human ovarian follicular fluid is pregnancy associated plasma protein-A. J Clin Endocrinol Metab, 84, 4742-5.

Cwyfan Hughes, S., Mason, H.D., Franks, S. & Holly, J.M. (1997). Modulation of the insulin-like growth factor-binding proteins by follicle size in the human ovary. J Endocrinol, 154, 35-43.

el-Roeiy, A., Chen, X., Roberts, V.J., LeRoith, D., Roberts, C.T., Jr. & Yen, S.S. (1993). Expression of insulin-like growth factor-I (IGF-I) and IGF-II and the IGF-I, IGF-II, and insulin receptor genes and localization of the gene products in the human ovary. J Clin Endocrinol Metab, 77, 1411-8.

el-Roeiy, A., Chen, X., Roberts, V.J., Shimasakai, S., Ling, N., LeRoith, D., Roberts, C.T., Jr. & Yen, S.S. (1994). Expression of the genes encoding the insulin-like growth factors (IGF-I and II), the IGF and insulin receptors, and IGF-binding proteins-1-6 and the localization of their gene products in normal and polycystic ovary syndrome ovaries, J Clin Endocrinol Metab, 78, 1488-96.

Elmlinger, MW., Bell, M., Schutt, BS., Langkamp, M., Kutoh, E. & Ranke, MB. (2001). Transactivation of the IGFBP-2 promoter in human tumor cell lines. Mol Cel Endocrinol, 175, 211-18.

Ferry, RJ. Jr., Cerri, RW. & Cohen, P. (1999). Insulin-like growth factor binding proteins: new proteins, new functions. Horm Res, 51, 53-67.

Gill, Z.P., Perks, C.M., Newcomb, P.V. & Holly, J.M. (1997). Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner. J Biol Chem, 272, 25602-7.
Giudice, L.C. (2001). Insulin-like growth factor family in Graafian follicle development and function. J Soc Gynecol Investig, 8,S26-9.

Giuice, L.C., Conover, C.A., Bale, L., Faessen, G.H., Iig, K., Sun, I., Imani, B., Suen, L.F., Irwin, J.C., Christiansen, M., Overgaard. M.T. & Oxvig, C. (2002). Identification and regulation of the IGFBP-4 protease and its physiological inhibitor in human trophoblasts and endometrial stroma: evidence for paracrine regulation of IGF-II bioavailability in the placental bed during human implantation. J Clin Endocrinol Metab, 87, 2359-66.

Giudice, L.C., van Dessel, H.J., Cataldo, N.A., Chandrasekher, Y.A., Yap, O.W. & Fauser, B.C. (1995). Circulating and ovarian IGF binding proteins: potential roles in normo-ovulatory cycles and in polycystic ovarian syndrome. Prog Growth Factor Res, 6, 397-408.

Glucman, PD. & Ambler, GR. (1993). What is the function of cicrulating insulin-like frowth factor-2 in postnatal life. Mol Cell Endocrinol, 92, C1-C3.

Gorodeski, GI. (1998). Estrogen increases the permeability of the cultured human cervical epithelium by modulating cell deformability. Am J Physiol, 275, C888-99.

Grimberg, A. & Cohen, P. (2000). Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J Cell Physiol, 183, 1, 1-9.

Guler, H.P., Zapf, J., Schmid, C. & Froesch, E.R. (1989). Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates. Acta Endocrinol (Copenh), 121, 753-8.

Hernandez, E.R. (1995). Regulation of the genes for insulin-like growth factor (IGF) I and II and their receptors by steroids and gonadotropins in the ovary. J Steroid Biochem Mol Biol, 53, 219-21.

Hourvitz, A., Widger, A.E., Filho, F.L., Chang, R.J., Adashi, E.Y. & Erickson, G.F. (2000). Pregnancy-associated plasma protein-A gene expression in human ovaries is restricted to healthy follicles and corpora lutea. J Clin Endocrinol Metab, 85, 4916-20.

Hourvitz, A., Widger, AE., Filho, FLT., Chang, RJ., Adashi, EY. & Erickson, GF. (2000). Pregnancy-associated plasma protein-A gene expression in human ovaries is restricted to healthy follicles and corpora lutea. J Clin Endocr Metab, 85, 4916-4919.

Hoeflich, A., Reisinger, R., Lahm, H., Kiess, W., Blum, WF., Kolb, HJ.,
Weber, MM. & Wolf, E. (2001). Insulin-like growth factor-binding protein 2 in tumorigenesis: protector or promoter? Cancer Res, 15, 8601-8610

Hwa, V., Oh, Y., Rosenfeld, R.G., Rajaram, S., Baylink, D.J. & Mohan, S. (1999). The insulin-like growth factor-binding protein (IGFBP) superfamily.

Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev, 20, 761-87.

Iwashita, M., Kudo, Y. & Takeda, Y. (1998). Effect of follicle stimulating hormone and insulin-like growth factors on proteolysis of insulin-like growth factor binding proteim-4 in human granulose cells. Mol Hum Reprod, 4, 401-5.

Iwashita, M., Kudo, Y., Yoshimura, Y., Adachi, T., Katayama, E. & Takeda, Y. (1996). Physiological role of insulin-like-growth-factor-binding protein-4 in human folliculogenesis. Horm Res, 1, 31-6.

Jesionowska, H., Hemmings, R., Guyda, H.J. & Posner, B.I. (1990). Determination of insulin and insulin-like growth factors in the ovarian circulation. Fertil Steril, 53, 88-91.

Jones, J.I. & Clemmons, D.R. (1995). Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev, 16, 3-34.


Jones, J.I., Gockerman, A., Busby, W.H., Jr., Wright, G. & Clemmons, D.R. (1993). Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence. Proc Natl Acad Sci U S A, 90, 10553-7.

Khan-Dawood, FS., Yang, J.& Dawood, MY. (1996). Localization and expression of zonula occludens-1 tight junction-associated protein in baboon (Papio anubis) corpora lutea. Hum Preprod, 11, 1262-67.

Kubota, T., Kamada, S., Ohara, M., Taguchi, M., Sakamoto, S., Shimizu, Y. & Aso, T. (1993). Insulin-like growth factor I in follicular fluid of the patients with in vitro fertilization and embryo transfer. Fertil Steril, 59, 844-9.

Lawrence, JB., Oxvig, C., Overgaard, MT., Sottrup-Jensen, L., Gleich, GJ., Hays, LG., Yates, JR.III. & Conover, CA. (1999). The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A.
Proc Nat Acad Sci, 96, 3149-3153.

Lee, PDK. & Rosenfeld, RG. (1987). Clinical utility of insulin-like growth factor assays. Pediatrication, 14, 154-61.

Liu, J., Antaya, M., Boerboom, D., Lussier, JG., Silversides, DW. & Sirois, J. (1999). The delayed activation of the prostaglandin G/H synthase-2 promoter in bovine granulosa cells is associated with down-regulation of truncated upstream stimulatory factor-2. J Biol Chem, 274, 35037-45.

Mazerbourg, S., Bondy, C., Zhou, J. & Monget, P. (2003). The Insulin-like Growth Factor System: a Key Determinant Role in the Growth and Selection of Ovarian Follicles? A Comparative Species Study. Reprod Domest Anim, 38, 247-258.

Mazerbourg, S., Overgaard, M.T., Oxvig, C., Christiansen, M., Conover, C.A., Laurendeau, I., Vidaud, M., Tosser-Klopp, G., Zapf, J. & Monget, P. (2001). Pregnancy-associated plasma protein-A (PAPP-A) in ovine, bovine, porcine, and equine ovarian follicles: involvement in IGF binding protein-4 proteolytic degradation and mRNA expression during follicular development. Endocrinology, 142, 5243-53.

Miell, JP., Langford, KS., Jones, JS., Noble, P., Westwood, M., White, A. & Nicolaides, KH. (1997). The maternal insulin-like growth factor (IGF)
and IGF-binding protein response to trisomic pregnancy during the
first trimester: a possible diagnostic tool.

Mohan, S., Nakao, Y., Honda, Y., Landale, E., Leser, U., Dony, C., Lang, K. & Baylink, D.J. (1995). Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells. J Biol Chem, 270, 20424-31.

Mullin, JM. (1997). Potential interplay between luminal growth factors and increased tight junction permeability in epithelial carcinogenesis. J Exp Zool, 279, 484-89.

Morgan, DO., Edman, JC., Standring, DN., Fried, VA., Smith, MC., Roth, RA. & Rutter, WJ. (1987). Insulin-like growth factor II receptor as a multifunctional binding protein. Nature, 329, 301-07.

Nissley, P. & Lopaczynski, W. (1991). Insulin-like growth factor receptors. Growth Factors, 5, 29-43.

Oh, Y., Muller, H.L., Lamson, G. & Rosenfeld, R.G. (1993a). Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition. J Biol Chem, 268, 14964-71.

Oh, Y., Muller, H.L., Pham, H., Rosenfeld, R.G. & Lamson, G. (1993b). Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells. J Biol Chem, 268, 26045-8.

Ortiz, C.O., Chen, B.K., Bale, L.K., Overgaard, M.T., Oxvig, C. & Conover, C.A. (2003). Transforming growth factor-beta regulation of the insulin-like growth factor binding protein-4 protease system in cultured human osteoblasts. J Bone Miner Res, 18, 1066-72.
Pellegrini, S., Fuzzi, B., Pratesi, S., Mannelli, M., Criscuoli, L., Messeri, G. & Forti, G. (1995). In-vivo studies on ovarian insulin-like growth factor I concentrations in human preovulatory follicles and human ovarian circulation. Hum Reprod, 10, 1341-5.

Peng, X., Maruo, T., Samoto, T. & Mochizuki, M. (1996). Comparison of immunocytologic localization of insulin-like growth factor binding protein-4 in normal and polycystic ovary syndrome human ovaries, Endocr J, 43, 269-78.

Piontkewitz, Y., Enerback, S. & Hedin, L. (1993). Expression and hormonal regulation of the CCAAT enhancer binding protein-alpha during differentiation of rat ovarian follicles. Endocrinology, 133, 2327-2333.
Poretsky, L., Cataldo, N.A., Rosenwaks, Z. & Giudice, L.C. (1999). The insulin-related ovarian regulatory system in health and disease, Endocr Rev, 20, 535-82.

Rajaram, S., Baylink, D.J. & Mohan, S. (1997). Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev, 18, 801-31.

Report on the nomenclature of the IGF binding proteins. (1992). Endocrinology, 130, 1736-1737.

Ramji, DP. & Foka P. (2002). CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J, 365, 561-575.

Rhoton-Vlasak, A., Gleich, G.J., Bischof, P. & Chegini, N. (2003). Localization and cellular distribution of pregnancy-associated plasma protein-a and major basic protein in human ovary and corpora lutea throughout the menstrual cycle. Fertil Steril, 79, 1149-53.

Rosenfeld, R. G., Wilson, D.M., Lee, P.D. & Hintz, R.L. (1986). Insulin-like growth factors I and II in evaluation of growth retardation. J Pediatr, 109, 428-33.


Rotwein, P. (1991). Structure, evolution, expression and regulation of insulin-like growth factors I and II. Growth Factors, 5, 3-18.

Rosenfeld, RG., Wilson, DM., Lee, PDK. & Hintz, RL. (1986). Insulin-like frowth factors I and II in evaluation of growth retardation. J Pediatr, 109, 428-33.

Rutanen, EM., Stenman, S., Blum, W., Karkkainen, T., Lehtovirta, P. & Stenman, UH (1993). Relationship between carbohydrate metabolism and serum insulinlike growth factor system in postmenopausal women: comparison of endometrial cancer patients with healthy controls. J Clin Endocrinol Metab, 77, 199-204.

Rutanen, EM., Pekonen, F. & Kärkkäinen, T. (1993). Measurement of insulin-like growth factor binding protein-1 in cervical/vaginal secretions: comparison with the ROM -check Membrane Immunoassay in the diagnosis of ruptured fetal membranes. Clin Chim Acta, 214, 73-81.

San Roman, G.A. & Magoffin, D.A. (1993). Insulin-like growth factor-binding proteins in healthy and atretic follicles during natureal menstrual cycles. J Clin Endocrinol Metab, 76, 625-32.

Sirois, J. & Richards, JS. (1993). Transcriptional regulation of rat prostaglandin endoperoxidase synthase 2 gene in granulosa cells. Evidence for the role of a cis-acting C/EBP b promoter element. J Biol Chem, 268, 21931-38.

Spratt, SK., Tatsuno, GP., Yaamanaka, MK., Ark, BC., Detmer, J., Mascarenhas, D., Flynn, J., Talkington-verser, C. & Spencer, EM. (1990). Cloning and expression of human insulin-like growth factor binding protein 3. Growth Factor, 3, 63-72.

Spoerri, PE., Caballero, S., Wilson, SH., Shaw, LC. & Grant, MB. (2003). Expression of IGFBP-3 by human retinal endothelial cell cultures: IGFBP-3 involvement in growth inhibition and apoptosis. Invest Ophthal Vis Sci, 44, 365-369.


Steer, C.V., Mills, C.L., Tan, S.L., Campbell, S. & Edwards, R.G. (1992). The cumulative embryo score: a predictive embryo scoring technique to select the optimal number of embryos to transfer in an in-vitro fertilization and embryo transfer programme. Hum reprod, 7, 117-9.

Sterneck, E., Tessarollo, L. & Johnson PF. (1997). An essential role for C/EBPB in female reproduction. Genes Dev, 11, 2153-62.

Stevenson, BR. & Keon, BH. (1998). The tight junction: morphology to molecules. Annu Rev Cell Dev Biol, 14, 89-109.

Sundfeldt, K., Piontkewitz, Y., Billing, H. & Hedin L. (2000). E-cadherin-catendin complex in the rat ovary: cell-specific expression during folliculogenesis and luteal formation. J Reprod Fertil, 118, 375-85.

Sun I.Y., Overgaard, M.T., Oxvig, C. & Giudice, L.C. (2002). Pregnancy-associated plasma protein A proteolytic activity is associated with the human placental trophoblast cell membrane. J Clin Endocrinol Metab, 87, 5235-40.

Teale, JD. (1994.) The diganostic application of serum grwoth hormone, insulin-like growth factor (IGF) and IGF binding protein measurements. JIFCC, 6, 164-8.

Wang, H.S. & Chard, T. (1992). The role of insulin-like growth factor-I and insulin-like growth factor-binding protein-1 in the control of human fetal growth. J Endocrinol, 132,11-9.

Wang, H.S. & Chard, T. (1999). IGFs and IGF-binding proteins in the regulation of human ovarian and endometrial function. J Endocrinol, 161, 1-13.

Wedel, A. & Ziegler-Heitbrock, HW. (1995). The C/EBP family of transcription factors. Immunobiology, 193, 171-185.



Weinzimer, SA., Gibson, TB., Collett-Solberg, PF., Khare, A., Liu, B. & Cohen, P. (2001). Transferrin is an insulin-like growth factor-binding protein-3 binding protein. J Clin Endocr Metab, 86, 1806-1813.
Westergaard, JG., Chemnitz, J., Teisner, B., Poulsen, HK., Ipsen, L., Beck, B. & Grudzinskas, JG. (1983). Pregnancy-associated plasma protein A: a possible marker in the classification and prenatal diagnosis of Cornelia de Lange syndrome. Prenatal Diag, 3, 225-232.

Wong, V., Ching, D., McCrea, PD.& Firestone, GL. (1999). Glucocorticoid down-regulation of fascin protein expression is required for the steroid-induced formation of tight junctions and cell-cell interactions in rat mammary epithelial tumor cells. J Biol Chem, 274, 5443-53.

Zhou, J. & Bondy, C. (1993). Anatomy of the human ovarian insulin-like growth factor system. Biol Reprod, 48, 467-82.

Zhou, J., Wang, J., Penny, D., Monget, P., Arraztoa, J.A., Fogelson, L.J. & Bondy, C.A. (2003a). Insulin-like growth factor binding protein 4 expression parallels luteinizing hormone receptor expression and follicular luteinization in the primate ovary. Biol Reprod, 69, 22-9.

Zhou, R., Diehl, D., Hoeflich, A., Lahm, H. & Wolf, E. (2003b). IGF-binding protein-4: biochemical characteristics and functional consequences. J Endocrinol, 178, 177-93.
QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top
無相關論文
 
系統版面圖檔 系統版面圖檔